Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Rheumatology and Therapy|October 4, 2023
Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled TrialCory Perugino, Emma L Culver, Arezou Khosroshahi, et al.
Rheumatology and Therapy|March 17, 2026
Efficacy and Safety of Obexelimab to Treat IgG4-Related Disease: Protocol for a Global, Randomized, Placebo-Controlled TrialEmma L Culver, Matthew C Baker, Emanuel Della-Torre, et al.
Rheumatology (Oxford, England)|January 29, 2021
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related diseaseLucrezia Rovati, Naoki Kaneko, Federica Pedica, et al.
Modern Rheumatology|September 14, 2016
Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickersMarco Lanzillotta, Corrado Campochiaro, Matteo Trimarchi, et al.
Clinical and Molecular Allergy : CMA|September 15, 2015
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps?Mona-Rita Yacoub, Matteo Trimarchi, George Cremona, et al.
The Journal of Allergy and Clinical Immunology|June 1, 2018
Identification of galectin-3 as an autoantigen in patients with IgG4-related diseaseCory A Perugino, Sultan B AlSalem, Hamid Mattoo, et al.
Vaccine|October 2, 2021
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccineMona-Rita Yacoub, Valentina Cucca, Chiara Asperti, et al.
The Journal of Allergy and Clinical Immunology|May 14, 2022
Distinct disease-specific Tfh cell populations in 2 different fibrotic diseases: IgG4-related disease and Kimura diseaseRyusuke Munemura, Takashi Maehara, Yuka Murakami, et al.
Frontiers in Immunology|May 17, 2021
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-InflammationEmanuel Della-Torre, Marco Lanzillotta, Corrado Campochiaro, et al.
Endoscopic Ultrasound|October 18, 2022
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control studySabrina Gloria Giulia Testoni, Maria Chiara Petrone, Michele Reni, et al.
Pageof 10